-transparent.png){kind=logo}
We present the first case of visceral leishmaniasis (VL) in a Spanish patient with HIV infection living in Belgium. After four weeks of stibogluconate and zidovudine treatment, the initially low CD4 count improved, and the splenomegaly regressed. VL is becoming frequently reported in association with HIV infection, especially in countries where leishmaniasis is endemic. The apparent effect of VL on the CD4 count may cause problems in the staging of HIV infections.
Related Publications
S L Chew, and
L Bedert, and
P Zachee, and
H Verbraeken, and
R L Colebunders
January 1989,
Enfermedades infecciosas y microbiologia clinica,
S L Chew, and
L Bedert, and
P Zachee, and
H Verbraeken, and
R L Colebunders
April 2013,
Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia,
S L Chew, and
L Bedert, and
P Zachee, and
H Verbraeken, and
R L Colebunders
February 1995,
Enfermedades infecciosas y microbiologia clinica,
S L Chew, and
L Bedert, and
P Zachee, and
H Verbraeken, and
R L Colebunders
July 1991,
Revista clinica espanola,
S L Chew, and
L Bedert, and
P Zachee, and
H Verbraeken, and
R L Colebunders
April 2005,
The Lancet. Infectious diseases,
S L Chew, and
L Bedert, and
P Zachee, and
H Verbraeken, and
R L Colebunders
August 1995,
Revista clinica espanola,
S L Chew, and
L Bedert, and
P Zachee, and
H Verbraeken, and
R L Colebunders
June 1996,
Minerva medica,
S L Chew, and
L Bedert, and
P Zachee, and
H Verbraeken, and
R L Colebunders
April 1994,
European journal of pediatrics,
S L Chew, and
L Bedert, and
P Zachee, and
H Verbraeken, and
R L Colebunders
February 1951,
Archivio per le scienze mediche,
S L Chew, and
L Bedert, and
P Zachee, and
H Verbraeken, and
R L Colebunders
October 1992,
Presse medicale (Paris, France : 1983),
